MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/clinem/dgaf693

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2026

Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study.

Chacko Shireen R, Sharma Shubhangi Sharma, Ahmadian Sarina, Saini Jasmine, Fell Vanessa, Peersen Anina F, Atkinson Elizabeth J, Gruber Lucinda, Van Gompel Jamie J, Simha Vinaya, Young William F, Bancos Irina

СтатьяПеревод в очереди

Аннотация

CONTEXT: Evidence on the evolution of cardiometabolic comorbidities following surgical remission of hypercortisolism is scarce.

OBJECTIVE

To determine the impact of surgical remission on cardiometabolic comorbidities in patients with endogenous hypercortisolism and to identify factors associated with cardiometabolic improvement.

METHODS

Prospective single-center cohort study (2019-2025) of adults with Cushing syndrome (CS) or mild autonomous cortisol secretion (MACS) with surgical remission of hypercortisolism. Outcomes included (1) changes in severity of hypertension, diabetes mellitus (DM), hyperlipidemia, and obesity between baseline, 3, and 12 months postremission and (2) factors associated with improvement in comorbidities.

RESULTS

Among 357 patients (49% MACS, 36% pituitary CS, 10% adrenal CS, 5% ectopic CS; median age 53 years [interquartile range 42-62]; 81% women), 336 (94%) had hypertension, 241 (68%) had obesity, and 122 (35%) had DM. At a median of 12 months postsurgery, improvement in hypertension occurred in 70% (90/128) of patients with CS and 51% (60/117) of patients with MACS, DM in 90% (46/51) patients with CS and 37% (13/35) patients with MACS, and obesity in 79% (77/97) patients with CS and 20% (14/71) patients with MACS. In a multivariable analysis, higher baseline biochemical severity scores were associated with improvement in hypertension [odds ratio (OR) 1.3, 95% confidence interval (CI) 1.1-1.5), DM (OR 2.5, 95% CI 1.7-4.1), and obesity (OR 1.5, 95% CI 1.2-1.8) at a median of 12 months postremission of hypercortisolism.

CONCLUSION

Postsurgical improvement of cardiometabolic comorbidities was observed in both patients with CS and MACS. Higher baseline biochemical severity scores were associated with higher postremission improvement in comorbidities.

Для цитирования: Chacko Shireen R, Sharma Shubhangi Sharma, Ahmadian Sarina, Saini Jasmine, Fell Vanessa, Peersen Anina F, Atkinson Elizabeth J, Gruber Lucinda, Van Gompel Jamie J, Simha Vinaya, Young William F, Bancos Irina. Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study.. The Journal of clinical endocrinology and metabolism. 2026. DOI: 10.1210/clinem/dgaf693.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.